Dr. Edward D King , MD
Urology • Ocala, FL
1901 Se 18th Ave, Bldg 300
Ocala, FL 344718215
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on July 8, 2005; this date does not establish years in practice.
-
Published CMS data list 45,620 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J1071 — Injection, testosterone cypionate, 1 mg: 24,701 service units.
- J0897 — Injection, denosumab, 1 mg: 4,800 service units.
- J9155 — Injection, degarelix, 1 mg: 4,160 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
See all 37 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 3,924 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl — 899 prescription fills, including refills.
- Oxybutynin Chloride Er (Oxybutynin Chloride) — 348 prescription fills, including refills.
- Finasteride — 297 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 39 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Urology in Florida (2024, 682 clinicians with data). Median for this group: 1,437. Middle half: 569 to 4,607.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 44,169 in 2020 to 45,620 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
1901 Se 18th Ave
Bldg 300
Ocala, FL 344718215
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Advanced Urology Institute Llc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Washington University School Of Medicine
1990
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
1,374 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $610,736 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $470,076 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
7,725 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$4,540,948 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $3,587.68 across 102 records.
By nature of payment
- Food and Beverage: $3,579.08 across 101 records.
- Education: $8.60 across 1 record.
Reporting-company totals (3 largest of 30)
- Ferring Pharmaceuticals Inc.: $460.33 across 6 records.
- Janssen Pharmaceuticals, Inc: $389.18 across 14 records.
- Procept Biorobotics Corporation: $316.12 across 3 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
36 years (graduated 1990)
CMS Doctors and Clinicians data list 1990 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2005
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. King has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. King as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Ocala and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Urology in Florida (2024, 682 clinicians with data). Median for this group: 1,437. Middle half: 569 to 4,607.
Too few clinicians listed under Urology in Ocala have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 90% of clinicians listed under Urology in Florida (2024, 682 clinicians with data). Median for this group: $126,394. Middle half: $52,949 to $270,891.
Too few clinicians listed under Urology in Ocala have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 90% of clinicians listed under Urology in Florida (2024, 682 clinicians with data). Median for this group: $92,960. Middle half: $39,365 to $204,092.
Too few clinicians listed under Urology in Ocala have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 70% of clinicians listed under Urology in Ocala, FL (2024, 12 clinicians with data). Median for this group: 1,753. Middle half: 60 to 3,973.
More Part D prescriptions than 90% of clinicians listed under Urology in Florida (2024, 725 clinicians with data). Median for this group: 1,339. Middle half: 366 to 2,301.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Urology in Ocala, FL (2024, 12 clinicians with data). Median for this group: $331,898. Middle half: $6,464 to $850,649.
A higher Part D drug cost than 95% of clinicians listed under Urology in Florida (2024, 725 clinicians with data). Median for this group: $137,247. Middle half: $24,439 to $468,865.
16 active clinicians are listed under Urology with a practice address in Ocala, FL (1,021 in Florida).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Ocala
18.8% of these 16 clinicians have the CMS telehealth indicator.
68.8% of these 16 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services stayed about the same: 44,169 in 2020 and 45,620 in 2024.
- 2020: 44,169
- 2021: 50,828
- 2022: 52,738
- 2023: 57,249
- 2024: 45,620
-
Medicare-allowed amount
Medicare-allowed amount increased 17% from $519,964 in 2020 to $610,736 in 2024.
- 2020: $519,964
- 2021: $472,731
- 2022: $440,250
- 2023: $453,827
- 2024: $610,736
-
Paid by Medicare
Paid by Medicare increased 20% from $391,432 in 2020 to $470,076 in 2024.
- 2020: $391,432
- 2021: $356,351
- 2022: $326,113
- 2023: $341,385
- 2024: $470,076
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 27% from 3,089 in 2020 to 3,924 in 2024.
- 2020: 3,089
- 2021: 3,283
- 2022: 3,477
- 2023: 3,560
- 2024: 3,924
-
30-day fills
30-day fills increased 32% from 5,849 in 2020 to 7,725 in 2024.
- 2020: 5,849
- 2021: 6,450
- 2022: 6,835
- 2023: 6,932
- 2024: 7,725
-
Part D drug cost
Part D drug cost increased 75% from $2,598,275 in 2020 to $4,540,948 in 2024.
- 2020: $2,598,275
- 2021: $2,717,818
- 2022: $1,762,704
- 2023: $2,155,901
- 2024: $4,540,948
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 79% from $17,125.46 in 2021 to $3,587.68 in 2025.
- 2021: $17,125.46
- 2022: $8,763.32
- 2023: $5,765.43
- 2024: $4,232.58
- 2025: $3,587.68
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 102 records totaling $3,587.68.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $161.32 |
| Procept Biorobotics Corporation |
Food and Beverage
Cash or cash equivalent
|
AQUABEAM ROBOTIC SYSTEM | General | $138.43 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
RYBREVANT | General | $134.99 |
| COLOPLAST CORP |
Food and Beverage
In-kind items and services
|
Porges Coloplast | General | $132.76 |
| BIOPROTECT MEDICAL, INC. |
Food and Beverage
In-kind items and services
|
BIOPROTECT BALLOON IMPLANT SYSTEM | General | $130.13 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $126.00 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $123.78 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $120.22 |
| Telix Pharmaceuticals |
Food and Beverage
In-kind items and services
|
ILLUCCIX | General | $115.38 |
| Procept Biorobotics Corporation |
Food and Beverage
In-kind items and services
|
AQUABEAM ROBOTIC SYSTEM | General | $111.24 |
| COLOPLAST CORP |
Food and Beverage
In-kind items and services
|
Porges Coloplast | General | $104.08 |
| AngioDynamics, Inc. |
Food and Beverage
In-kind items and services
|
NANOKNIFE | General | $102.80 |
| Tempus AI, Inc |
Food and Beverage
In-kind items and services
|
XT CDX | General | $99.39 |
| Telix Pharmaceuticals |
Food and Beverage
In-kind items and services
|
ILLUCCIX | General | $70.72 |
| Procept Biorobotics Corporation |
Food and Beverage
In-kind items and services
|
AQUABEAM ROBOTIC SYSTEM | General | $66.45 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $49.82 |
| Tempus AI, Inc |
Food and Beverage
In-kind items and services
|
XT CDX | General | $44.14 |
| COLOPLAST CORP |
Food and Beverage
In-kind items and services
|
Porges Coloplast | General | $40.00 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $32.62 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $31.72 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $31.28 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $30.07 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $29.97 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $29.86 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $29.65 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J1071
Injection, testosterone cypionate, 1 mg
|
24,701 | 17 | $0.36 | $0.02 |
|
J0897
Injection, denosumab, 1 mg
|
4,800 | 21 | $46.73 | $25.47 |
|
J9155
Injection, degarelix, 1 mg
|
4,160 | 17 | $8.54 | $4.18 |
|
J9030
Bcg live intravesical instillation, 1 mg
|
2,450 | 17 | $5.16 | $2.77 |
|
81003
Automated urinalysis test
|
1,991 | 1,172 | $5.00 | $2.19 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
1,702 | 1,110 | $38.31 | $17.02 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
1,050 | 783 | $215.86 | $92.96 |
|
36415
Insertion of needle into vein for collection of blood sample
|
946 | 667 | $11.14 | $7.07 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
836 | 635 | $316.98 | $131.80 |
|
A9579
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml
|
582 | 33 | $3.50 | $1.48 |
|
99490
Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
|
365 | 78 | $155.25 | $65.00 |
|
J9217
Leuprolide acetate (for depot suspension), 7.5 mg
|
286 | 39 | $350.73 | $178.11 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
251 | 194 | $26.40 | $11.25 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
198 | 162 | $492.98 | $84.19 |
|
96372
Injection of drug or substance under skin or into muscle
|
180 | 39 | $35.00 | $14.54 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
176 | 176 | $417.30 | $172.86 |
|
74018
X-ray of abdomen, 1 view
|
169 | 136 | $64.19 | $30.34 |
|
96402
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
|
110 | 47 | $82.39 | $35.37 |
|
99439
Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month
|
109 | 51 | $118.07 | $49.56 |
|
76872
Ultrasound scan of pelvic region through rectum
|
75 | 71 | $129.37 | $33.20 |
|
72197
Mri scan of pelvis before and after contrast
|
68 | 34 | $524.09 | $172.83 |
|
72195
Mri scan of pelvis without contrast
|
65 | 33 | $365.37 | $119.92 |
|
51720
Instillation of anti-cancer drug into bladder
|
60 | 20 | $217.33 | $87.78 |
|
55700
Biopsy of prostate gland
|
55 | 53 | $546.40 | $133.51 |
|
51702
Simple insertion of temporary bladder tube
|
32 | 18 | $154.25 | $63.32 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 899 | 74,619 | $12,757.85 | 311 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 348 | 22,950 | $9,407.98 | 147 |
| Finasteride | Finasteride | 297 | 26,258 | $4,328.93 | 97 |
| Levofloxacin | Levofloxacin | 263 | 1,387 | $786.44 | 226 |
| Myrbetriq | Mirabegron | 221 | 14,193 | $209,230.90 | 69 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 216 | 466 | $1,060.47 | 196 |
| Xtandi | Enzalutamide | 199 | 5,955 | $2,724,643.40 | 28 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 173 | 1,264 | $1,320.38 | 123 |
| Orgovyx | Relugolix | 129 | 3,848 | $339,145.62 | 16 |
| Methenamine Hippurate | Methenamine Hippurate | 120 | 6,560 | $9,114.76 | 30 |
| Testosterone | Testosterone | 105 | 3,840 | $22,567.15 | 23 |
| Testosterone Cypionate | Testosterone Cypionate | 77 | 6,137 | $5,454.18 | 28 |
| Tadalafil | Tadalafil | 67 | 3,152 | $5,390.20 | 20 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 63 | 5,541 | $1,429.95 | 23 |
| Sildenafil Citrate | Sildenafil Citrate | 55 | 1,632 | $778.65 | 24 |
| Erleada | Apalutamide | 54 | 1,620 | $826,339.15 | — |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 53 | 884 | $1,358.80 | 42 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 48 | 1,974 | $948.47 | 35 |
| Gemtesa | Vibegron | 47 | 2,647 | $41,762.75 | 16 |
| Cephalexin | Cephalexin | 44 | 1,159 | $301.80 | 34 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 38 | 2,576 | $4,487.56 | 15 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 34 | 258 | $141.02 | 31 |
| Prednisone | Prednisone | 33 | 1,050 | $257.86 | — |
| Abiraterone Acetate | Abiraterone Acetate | 30 | 900 | $32,264.52 | — |
| Oxybutynin Chloride | Oxybutynin Chloride | 29 | 2,610 | $584.06 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2021-01-05NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20090106000606
FL
2668534553
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Advanced Urology Institute Llc
1901 Se 18th Ave, Ocala, FL 344718214
Phone: 3523511313
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner - Family
Nurse Practitioner (Certified)
Urology
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Nurse Practitioner - Family
Advanced Practice Registered Nurse
Urology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 12109 COUNTY ROAD 103, OXFORD, FL 344842951 (Tel: 3522058981)
NPI status registered as active in NPPES database
Registered at 1901 SE 18TH AVE, BLDG 300, OCALA, FL 344718215 (Tel: 3523511313)
Registered at 12109 CR 103, OXFORD, FL 344842967 (Tel: 3523916494)
Recorded as EDWARD KING, MD
Urology (license number reported to NPPES: FL ME0071268)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Urology Specialists in Ocala
- Dr. Charles King, MD
- Dr. Harvey Taub, MD
- Dr. John Thompson, MD
- Dr. Devon Thomas, MD
- Dr. Amit Chakrabarty, MD
- Dr. Joseph Cline, MD
Mailing Address
12109 County Road 103
Oxford, FL 344842951
Phone: 3522058981